Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Donley Matthew Maxwell
Chief Operating Officer at Aurinia Pharmaceuticals. Filing since 11 May 2021.
CIK 0001636642
Company
Date
Role
Action
Shares
Amount
Of holding
AUPH
Aurinia Pharmaceuticals Inc.
4 Mar 2025
Chief Operating Officer
Sold at will
58,991
$467.21K
8.0%
AUPH
Aurinia Pharmaceuticals Inc.
3 Mar 2025
Chief Operating Officer
Sold at will
65,902
$527.22K
8.2%
AUPH
Aurinia Pharmaceuticals Inc.
6 Mar 2024
EVP, Ops & Strategy
Sold at will
40,665
$224.06K
6.5%
AUPH
Aurinia Pharmaceuticals Inc.
21 Nov 2022
Ex VP, Internal Operations
Bought
10,000
$46.60K
55.8%
AUPH
Aurinia Pharmaceuticals Inc.
2 Mar 2022
Ex VP, Intern'l Operations
Sold, plan not stated
3,052
$36.65K
15.8%
AUPH
Aurinia Pharmaceuticals Inc.
11 May 2021
Ex VP, Intern'l Operations
Bought
9,900
$99.74K
opened
6 decisions on file.
